CompletedNCT01570907
Quetiapine 25 mg: Bioequivalence Without Food
About this title
Read the official source — NCT01570907Medication studyAges 18–45United StatesBipolarity
Understand this study
Who was this study for?
Listed age limits: 18 years to 45 years.
- Listed locations
- HoustonSee all locations and recruitment
Study information
Study start dateJune 2007
- Recruitment status
- Completed
- Enrollment listed in the registry
- 42
- Sponsor
- Roxane Laboratories
- Sponsor type
- Pharmaceutical company
- Study type
- Drug
- Intervention type
- Drug
- Locations
- United States
- Age range
- From 18 Years to 45 Years
- Official registry ID
- NCT01570907
- Official title
Show the full official title
A Single Dose, Two-Period, Two-Treatment, Two-Sequence Crossover Bioequivalency Study of Quetiapine Fumarate 25 mg Tablets Under Fasting Conditions
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Houston
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Roxane Laboratories, a pharmaceutical company.
Did this study involve medication?
Yes. The study involved medication, including Quetiapine Fumarate.
Who was this study for?
Listed age limits: 18 years to 45 years.
